A Grant Framework as a Push Incentive to Stimulate Research and Development of New Antibiotics.

The article focuses on a review of databases of small- to medium-sized businesses focusing on research and development (R&D) of antibacterial agents. It comments on retrospective grand funding by several U.S. agencies and public-private partnerships using the National Institutes of Health's database. It mentions multinational organizations supporting R&D and the European Union's Joint Programming Initiative on Antimicrobial Resistance to coordinate efforts in the antimicrobial resistance field.